2023年度胰腺外科治疗进展及焦点展望
Progress of pancreatic surgical treatment in 2023
王若冰 1刘悦泽 1张太平1
作者信息
- 1. 中国医学科学院北京协和医学院 北京协和医院基本外科,北京 100730
- 折叠
摘要
胰腺外科是普通外科领域内最具挑战性的专科.由于胰腺外科疾病种类多,手术难度高,不同病种间诊疗思路存在差异,仍有许多争议亟待解决.本文从胰腺炎、胰腺囊性疾病、胰腺神经内分泌肿瘤、胰腺癌的外科治疗,以及新辅助治疗、辅助治疗、免疫及靶向治疗等方面,对2023年胰腺外科临床与转化研究的前沿进展进行归纳与梳理,以期进一步规范胰腺外科诊治.
Abstract
Pancreatic surgery is one of the most challenging specialties in general surgery.Due to the variety of pancreatic diseases,the difficulty of surgery,and the differences in diagnosis and treatment among different diseases,treatment strategies for these diseases remain controversial.From the aspects of surgical treatment such as pancreatitis,pancreatic cystic neoplasms,pancreatic neuroendocrine neoplasms,and pancreatic cancer,as well as neoadjuvant therapy,adjuvant therapy,immunotherapy,and targeted therapy.We review and summarize the frontier progress of clinical and translational research in pancreatic surgery in 2023,in order to further standardize the diagnosis and treatment of pancreatic surgery.
关键词
胰腺炎/胰腺肿瘤/手术治疗/新辅助治疗/进展Key words
Pancreatitis/Pancreatic neoplasms/Surgical treatment/Neoadjuvant therapy/Progress引用本文复制引用
出版年
2024
NETL
NSTL
维普
万方数据